Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Telemetry devices to monitor cardiac patients: a review of the safety and guidelines
2012	Health Information and Quality Authority (HIQA)	Health technology assessment of a national deep brain stimulation service in Ireland
2012	HAYES, Inc.	Pulmonary thromboendarterectomy for treatment of pulmonary hypertension
2012	Agency for Healthcare Research and Quality (AHRQ)	Noninvasive technologies for the diagnosis of coronary artery disease in women
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2012	HAYES, Inc.	Qsymia (phentermine/topiramate; Vivus Inc.) for obesity management
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	Asian study on the value for a QALY: Korean results
2012	HAYES, Inc.	Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for percutaneous coronary intervention in coronary artery disease
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Infliximab versus methotrexate, etanercept, adalimumab, and ustekinumab for plaque psoriasis: a review of the comparative clinical efficacy, safety and cost effectiveness
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Screening for colorectal cancer part 1: screening-tests and program design
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in adults
2012	Medical Services Advisory Committee (MSAC)	Testing for HER-2 status in advanced or metastatic breast cancer (stage IIIA-IV) to access lapatinib
2012	Agency for Healthcare Research and Quality (AHRQ)	Registry of patient registries (RoPR): policies and procedures
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterile pre-filled saline syringes for acute care patients: a review of clinical evidence, cost-effectiveness, evidence-based guidelines, and safety
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Lenalidomide (Revlimid®) for the first-line therapy of transplant-ineligible patients with multiple myeloma
2012	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in children
2012	Agency for Healthcare Research and Quality (AHRQ)	Treatment for glaucoma: comparative effectiveness
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Modafinil for sleep disorders and fatigue secondary to multiple sclerosis: a review of the clinical efficacy and safety
2012	HAYES, Inc.	Sacroiliac joint fusion for the treatment of adult low back pain
2012	Medical Services Advisory Committee (MSAC)	Holmium Laser Enucleation of the Prostate (HOLEP) combined with tissue morcellation
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Subcutaneous immunotherapy for the treatment of allergies: a review of the clinical efficacy, safety and guidelines
2012	HAYES, Inc.	Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electrocardiograms versus x-rays for guided placement of central venous catheter tips: a review of clinical and cost-effectiveness
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012	Agency for Healthcare Research and Quality (AHRQ)	Management of asymptomatic carotid stenosis
2012	HAYES, Inc.	Xoft Axxent eBx electronic brachytherapy system (iCAD Inc.) for early-stage breast cancer
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sodium chloride inhalation for the treatment of cystic fibrosis: a review of the clinical evidence, cost-effectiveness and guidelines
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2012	HAYES, Inc.	Accelerated partial breast irradiation for breast cancer using conformal and intensity-modulated radiation therapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug eluting stents in adults with acute coronary syndrome: a review of the clinical effectiveness, safety and guidelines
2012	HAYES, Inc.	SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2012	HAYES, Inc.	Antibiotic-coated sutures
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-alcohol hand sanitizers for non-healthcare personnel: a review of the clinical effectiveness and guidelines
2012	HAYES, Inc.	Solesta (Q-Med AB) for treatment of fecal incontinence
2012	Agency for Healthcare Research and Quality (AHRQ)	The impact of pre-transplant red blood cell transfusions in renal allograph rejection
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Adaptive servo ventilation versus continuous or bi-level positive airway pressure: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012	HAYES, Inc.	Somatosensory evoked potentials (SEPs) for intraoperative monitoring during spinal cord surgery for trauma or tumors
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electronic cigarettes: a review of the clinical evidence and safety
2012	HAYES, Inc.	Sphincter pharyngoplasty for velopharyngeal insufficiency in children
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Therapy dogs and horses for mental health: a review of the clinical effectiveness
2012	HAYES, Inc.	Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2012	Basque Office for Health Technology Assessment (OSTEBA)	[They just told me I have diabetes! Guide for youth and adults with type 1 diabetes and in intensive treatment]
2012	Medical Advisory Secretariat (MAS)	Chronic Obstructive Pulmonary Disease (COPD)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug eluting stents in adults with in-stent restenosis: a review of the clinical effectiveness, safety and guidelines
2012	HAYES, Inc.	Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lymphocyte transformation testing (LTT) or lymphocyte proliferation testing (LPT) for hip or knee arthroplasty: a review of clinical and cost-effectiveness, and evidence-based guidelines
2012	HAYES, Inc.	VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2012	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Falls prevention for the elderly]
2012	Agency for Healthcare Research and Quality (AHRQ)	Enabling patient-centered care through health information technology (Health IT)
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Evaluation of acellular dermal matrix for breast reconstruction: an update
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dual antiplatelet therapy and enoxaparin or unfractionated heparin for patients with ST-elevation myocardial infarction: a review of the clinical evidence
2012	HAYES, Inc.	X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	A systematic review of intravitreal bevacizumab for the treatment of diabetic macular edema
2012	HAYES, Inc.	Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC)
2012	HTA Unit, University of Calgary	A health technology assessment of transient elastography in liver disease
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis: clinical effectiveness and harms
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Insulin detemir (Levemir®) 100 U/ml solution for injection
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	The hybrid operating room. Should one be available for cardiovascular-thoracic procedures in the MUHC? A brief report
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Reducing pneumonia readmissions
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Fidaxomicin (Dificlir®) 200 mg film-coated tablets
2012	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Single-dose intraoperative radiotherapy using Intrabeam® for early-stage breast cancer: a health technology assessment
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Reducing AMI readmissions
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Degarelix (Firmagon®) 80 mg and 120 mg subcutaneous injection
2012	HAYES, Inc.	C-abl oncogene 1, nonreceptor tyrosine kinase (ABL1) variant testing in acquired tyrosine kinase inhibitor (TKI) resistance
2012	HAYES, Inc.	Massage therapy for autism spectrum disorders in children
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Condom catheter use and catheter-associated urinary tract infections
2012	Agency for Healthcare Research and Quality (AHRQ)	Measuring health-related quality of life for patients with diabetic retinopathy
2012	HAYES, Inc.	CancerTYPE ID® (bioTheranostics Inc.) for cancer of unknown primary (CUP)
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Implantable cardiac devices: implications for outpatient endoscopy
2012	Agency for Healthcare Research and Quality (AHRQ)	Systematic review of ECG-based signal analysis technologies for evaluating patients with acute coronary syndrome
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Medications for treating acutely agitated or aggressive behavior in pediatric emergency patients
2012	Agency for Healthcare Research and Quality (AHRQ)	Update on mapping the landscape of genetic tests for non-cancer diseases/conditions
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Credentialing for robotic-assisted surgery
2012	Adelaide Health Technology Assessment (AHTA)	Television marketing of unhealthy food and beverages to children in Australia: a review of published evidence from 2009
2012	Belgian Health Care Knowledge Centre (KCE)	Performance of the Belgian Health System. Report 2012
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Reducing heart failure readmissions
2012	Belgian Health Care Knowledge Centre (KCE)	Models for citizen and patient involvement in health care policy part I: exploration of their feasibility and acceptability
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Transfer of neurointensive care patients
2012	Belgian Health Care Knowledge Centre (KCE)	A national clinical practice guideline on the management of localised prostate cancer - Part 1
2012	Belgian Health Care Knowledge Centre (KCE)	Manual for cost-based pricing of hospital interventions
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Colchicine for prevention of percarditis and atrial fibrilation
2012	Belgian Health Care Knowledge Centre (KCE)	A national guideline for the prevention of pressure ulcers
2012	NIHR Health Technology Assessment programme	Mode of data elicitation, acquisition and response to surveys: a systematic review
2012	HAYES, Inc.	Screening, Brief Intervention, and Referral to Treatment (SBIRT) using remote interventions for alcohol misuse
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to improve patient satisfaction
2012	Belgian Health Care Knowledge Centre (KCE)	Evolution of day care: impact of financing and regulations
2012	Technology Assessment at SickKids (TASK)	The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Inpatient pharmacist interventions: impact on ED visits, readmissions, length of stay, mortality, patient knowledge, medication adherence, and patient satisfaction
2012	Belgian Health Care Knowledge Centre (KCE)	Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy
2012	Belgian Health Care Knowledge Centre (KCE)	Hepatitis C screening and prevention
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: RhinoChill® intranasal cooling device for protective cooling the brain after a cerebral ischaemic event
2012	Belgian Health Care Knowledge Centre (KCE)	Organisation of care for chronic patients in Belgium: development of a position paper
2012	NIHR Health Technology Assessment programme	A systematic review of the clinical effectiveness and cost effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Denosumab (Xgeva) for recurrent or unresectable giant cell tumour of the bone – first or second line
2012	Belgian Health Care Knowledge Centre (KCE)	Neuromodulation for the management of chronic pain: implanted spinal cord stimulators and intrathecal analgesic delivery pumps
2012	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation
2012	HAYES, Inc.	Spinal cord stimulation for relief of neuropathic pain
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Trastuzumab (Herceptin) for HER2 positive early breast cancer – two year regimen
2012	Belgian Health Care Knowledge Centre (KCE)	Vaccine safety surveillance in Belgium : place and limits of a background rate approach